Enhance MD NAD+ review

The wafer selector labels its tiers 12, six, three and one month, but states billing every 48, 24, 12 and four weeks respectively. The corresponding displayed monthly expressions are $84, $89, $94 and $99. Four weeks is not a calendar month. The page does not print the full amount collected at each renewal alongside these expressions, so we do not calculate an assumed upfront total.

Opening the injection tab shows explicit subcutaneous administration. It displays $169, $179, $189 and $199 per month beside billing every 48, 24, 12 and four weeks respectively. The $169 starting expression belongs to the 48-week tier and is repeated in the comparison table. No complete upfront total is printed alongside these injection tiers. The wafer treatment is sublingual NAD+ rather than an NR or NMN precursor. Neither tab clearly maps its advertised payment to a specific medication quantity. The wafer inclusion list even says vials, so request the actual formulation and supply details.

The page lists ongoing provider care and support. Its shipping policy includes two-day priority shipping in the displayed pricing, while warning that medical review occurs before dispatch and delivery timing is not guaranteed. Those are useful inclusions, but they do not establish that every pictured box or vial is supplied with the selected plan.